Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

被引：0
|
作者：
Vivian P. Bykerk
Gerd R. Burmester
Bernard G. Combe
Daniel E. Furst
Tom W. J. Huizinga
Harris A. Ahmad
Paul Emery
机构：
[1] Weill Cornell Medical College,Department of Rheumatology, Hospital for Special Surgery
[2] Charité–University Medicine Berlin,Department of Rheumatology and Clinical Immunology
[3] Service d’Immuno-Rheumatologie,Department of Rheumatology
[4] University of California Los Angeles,Department of Medicine
[5] Leiden University Medical Center,Department of Rheumatology
[6] Bristol-Myers Squibb,Headquarters Medical Immunology
[7] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[8] Leeds Teaching Hospitals NHS Trust,NIHR Leeds Musculoskeletal Biomedical Research Unit
来源：
Rheumatology International | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access.
引用
下载
收藏
页码：945 / 945
相关论文
共 50 条
  • [1] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2225 - 2231
  • [2] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2018, 38 : 2225 - 2231
  • [3] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis (vol 38, pg 2225, 2018)
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (05) : 945 - 945
  • [4] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, V. P.
    Burmester, G. R.
    Combe, B. G.
    Furst, D. E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, P.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 42 - 42
  • [5] On Drug and Drug-Free Remission By Baseline Disease Duration: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis
    Bykerk, V. P.
    Burmester, Gerd
    Combe, B. G.
    Furst, Daniel E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [6] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, V. P.
    Burmester, G. R.
    Combe, B. G.
    Furst, D. E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 477 - 478
  • [7] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, Vivian
    Burmester, Gerd
    Combe, Bernard
    Furst, Daniel E.
    Huizinga, Tom
    Wong, Daniel
    Emery, Paul
    RHEUMATOLOGY, 2016, 55 : 97 - 98
  • [8] Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
    Emery, P.
    Burmester, Gerd
    Bykerk, Vivian P.
    Combe, B.
    Furst, D. E.
    Barre, E.
    Karyekar, C. S.
    Wong, D.
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1084 - S1084
  • [9] PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS
    Emery, Paul
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Combe, Bernard G.
    Furst, Daniel E.
    Karyekar, Chetan S.
    Wong, Dennis A.
    Huizinga, Tom W. J.
    RHEUMATOLOGY, 2015, 54 : 28 - 29
  • [10] FACTORS ASSOCIATED WITH PERSISTENT DRUG-FREE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Valor, Larissa
    Hagen, Melanie
    Reiser, Michaela
    Kleyer, Arnd
    Hartmann, Fabian
    Manger, Bernhard
    Schett, Georg
    Rech, Juergen
    Tascilar, Koray
    Haschka, J.
    Englbrecht, M.
    Hueber, A.
    Figueiredo, C.
    Fogagnolo, J.
    Tony, H. P.
    Finzel, S.
    Kleinert, S.
    Wendler, J.
    Schuch, F.
    Ronneberger, M.
    Feuchtenberger, M.
    Fleck, M.
    Manger, K.
    Ochs, W.
    Schmitt-Haendle, M.
    Lorenz, H. M.
    Nuesslein, H.
    Alten, R.
    Henes, J.
    Krueger, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 730 - 730
12345